MREO
Mereo Biopharma Group Plc ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.39
+0.00 -0.23%
🌙 3월 13일 7:49 PM ET (한국 3/14 08:49)
$0.39
+0.00 +0.78%
| Index | - | P/E | - | EPS (ttm) | -0.26 | Insider Own | - | Shs Outstand | 0.16B | Perf Week | -2.06% |
| Market Cap | 0.06B | Forward P/E | - | EPS next Y | 42.93% | Insider Trans | - | Shs Float | 0.16B | Perf Month | -2.3% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.01 | Inst Own | 42.21% | Short Float | 8.65% | Perf Quarter | -83.29% |
| Income | -0.04B | P/S | 120.42 | EPS this Y | 1% | Inst Trans | -31.91% | Short Ratio | 0.91 | Perf Half Y | -78.79% |
| Sales | 0.00B | P/B | 1.32 | EPS next 5Y | 12.64% | ROA | -58.58% | Short Interest | 13.76M | Perf YTD | -7.37% |
| Book/sh | 0.29 | P/C | 1.26 | EPS past 3/5Y | - 34.82% | ROE | -70% | 52W High | -87.34% ($3.05) | Perf Year | -84.56% |
| Cash/sh | 0.31 | P/FCF | - | Sales past 3/5Y | - | ROIC | -89.48% | 52W Low | 93% ($0.20) | Perf 3Y | -55.32% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -5.44% | Gross Margin | 73.6% | Volatility(W/M) | 6.82% 9.18% | Perf 5Y | -90.54% |
| Dividend TTM | - | EV/Sales | 25.71 | Sales Y/Y TTM | - | Oper. Margin | -9336.02% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.71 | EPS Q/Q | 55.69% | Profit Margin | -8236.88% | RSI (14) | 37.83 | Recom | 1.62 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.71 | Sales Q/Q | - | SMA20 | -3.32% ($0.4) | Beta | 0.31 | Target Price | $3.44 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 11000000 | SMA50 | -13.91% ($0.45) | Rel Volume | 0.1 | Prev Close | $0.39 |
| Employees | 36 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -75.44% -98.29% | SMA200 | -76.06% ($1.63) | Avg Volume(3M) | 15.19M | Price | $0.39 |
| IPO | 2019/4/24 | Option/Short | Yes/Yes | Trades | 1900 | Volume | 1,485,380 | Change | -0.23% |
뉴스 로딩 중...